Overview
JAZZ market data
Price History
JAZZ price chart
Valuation & Profitability
- P/E (TTM)
- 536.83 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$5.84 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.37 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $105.00 – $255.20 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $15.8K · P/B 2.39 · P/S 3.57.
Company news
Global Payments To Rally More Than 28%? Here Are 10 Top Analyst Forecasts For MondayBenzinga · Jul 20, 2026, 11:40 AM
Needham Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $282Benzinga · Jul 20, 2026, 10:36 AM
This Moody's Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For FridayBenzinga · Jul 17, 2026, 11:15 AM
Canaccord Genuity Initiates Coverage On Jazz Pharmaceuticals with Buy Rating, Announces Price Target of $290Benzinga · Jul 17, 2026, 10:36 AM
Micron To Rally Around 87%? Here Are 10 Top Analyst Forecasts For TuesdayBenzinga · Jul 14, 2026, 12:19 PM
Wells Fargo Maintains Overweight on Jazz Pharmaceuticals, Raises Price Target to $285Benzinga · Jul 14, 2026, 11:33 AM
Barclays Maintains Overweight on Jazz Pharmaceuticals, Raises Price Target to $260Benzinga · Jul 14, 2026, 11:05 AM
Deutsche Bank Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $270Benzinga · Jul 9, 2026, 7:00 PM
Truist Securities Maintains Buy on Jazz Pharmaceuticals, Lowers Price Target to $254Benzinga · Jul 7, 2026, 12:30 PM
Jazz Pharmaceuticals Gains Oncology Firepower Through AbCellera CollaborationBenzinga · Jun 17, 2026, 5:00 PM